Detalhe da pesquisa
1.
Genome-wide association study identifies novel susceptibility loci for KIT D816V positive mastocytosis.
Am J Hum Genet
; 108(2): 284-294, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33421400
2.
Differential inhibition of T-cell receptor and STAT5 signaling pathways determines the immunomodulatory effects of dasatinib in chronic phase chronic myeloid leukemia.
Haematologica
; 108(6): 1555-1566, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36700403
3.
Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype.
Br J Haematol
; 198(6): 1011-1015, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802024
4.
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference.
J Allergy Clin Immunol
; 147(6): 2043-2052, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33745886
5.
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre.
Br J Haematol
; 193(4): 792-797, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33751548
6.
Altered immune response to the annual influenza A vaccine in patients with myeloproliferative neoplasms.
Br J Haematol
; 193(1): 150-154, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33159465
7.
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutations.
Br J Haematol
; 194(2): 344-354, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34060083
8.
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia.
Br J Haematol
; 194(6): 999-1006, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34085278
9.
The clinical and pathological panoply of systemic mastocytosis.
Br J Haematol
; 188(5): 623-640, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31985050
10.
Essential thrombocythaemia treated with recombinant interferon: 'real world' United Kingdom referral centre experience.
Br J Haematol
; 186(4): 561-564, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31090926
11.
Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review.
Haematologica
; 104(8): 1580-1588, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30679326
12.
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group.
Haematologica
; 102(1): 85-93, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27540137
13.
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.
J Allergy Clin Immunol
; 137(1): 35-45, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26476479
14.
The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group.
Cancer
; 122(12): 1888-96, 2016 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27070130
15.
Disease characteristics and outcomes in younger adults with primary and secondary myelofibrosis.
Br J Haematol
; 175(1): 37-42, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27293069
16.
Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Br J Haematol
; 193(4): 692-696, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33719038
17.
Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients.
Blood
; 123(24): 3803-10, 2014 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24553173
18.
Ruxolitinib: evolution or revolution in treatment of patients with polycythemia vera?
Future Oncol
; 12(6): 739-49, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26846873
19.
Outcomes of patients receiving direct oral anticoagulants for myeloproliferative neoplasm-associated venous thromboembolism in a large tertiary centre in the UK.
Br J Haematol
; 189(3): e79-e81, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32011726
20.
Mast cell activation syndrome: Importance of consensus criteria and call for research.
J Allergy Clin Immunol
; 142(3): 1008-1010, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29928922